Y. Terashima

872 total citations
35 papers, 701 citations indexed

About

Y. Terashima is a scholar working on Rheumatology, Oncology and Surgery. According to data from OpenAlex, Y. Terashima has authored 35 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Y. Terashima's work include Rheumatoid Arthritis Research and Therapies (7 papers), Musculoskeletal synovial abnormalities and treatments (3 papers) and Orthopedic Infections and Treatments (3 papers). Y. Terashima is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Musculoskeletal synovial abnormalities and treatments (3 papers) and Orthopedic Infections and Treatments (3 papers). Y. Terashima collaborates with scholars based in Japan and United States. Y. Terashima's co-authors include Aikou Okamoto, Yuichi Sameshima, M Terada, Takashi Sügimura, Jun Yokota, Yutaka Oiso, Masakuni Furusato, Kunïkazu Kondo, Shin‐ichi Teshima and Hiroshi Sasaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

Y. Terashima

33 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Terashima Japan 13 256 213 186 158 149 35 701
Robin Fuchs‐Young United States 19 329 1.3× 246 1.2× 333 1.8× 132 0.8× 49 0.3× 36 1.0k
Daniela Annibali Belgium 18 601 2.3× 295 1.4× 93 0.5× 257 1.6× 49 0.3× 29 1.0k
Fangfang Bi China 21 560 2.2× 194 0.9× 167 0.9× 347 2.2× 60 0.4× 48 984
Hung‐Pei Tsai Taiwan 14 287 1.1× 121 0.6× 97 0.5× 142 0.9× 34 0.2× 68 732
Youji Feng China 12 350 1.4× 187 0.9× 107 0.6× 129 0.8× 29 0.2× 33 582
Tatsuhiro Ohgami Japan 15 241 0.9× 151 0.7× 85 0.5× 97 0.6× 28 0.2× 40 602
Lillian Marie Swiersz United States 7 203 0.8× 40 0.2× 208 1.1× 92 0.6× 122 0.8× 8 661
Dwight E. Saunders United States 14 212 0.8× 163 0.8× 43 0.2× 102 0.6× 218 1.5× 18 675
Armina A. Kazi United States 13 394 1.5× 205 1.0× 57 0.3× 192 1.2× 24 0.2× 22 708
David S. Loose‐Mitchell United States 14 326 1.3× 114 0.5× 113 0.6× 53 0.3× 26 0.2× 19 824

Countries citing papers authored by Y. Terashima

Since Specialization
Citations

This map shows the geographic impact of Y. Terashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Terashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Terashima more than expected).

Fields of papers citing papers by Y. Terashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Terashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Terashima. The network helps show where Y. Terashima may publish in the future.

Co-authorship network of co-authors of Y. Terashima

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Terashima. A scholar is included among the top collaborators of Y. Terashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Terashima. Y. Terashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Teppei, Takahiro Yoshikawa, Tetsuya Furukawa, et al.. (2025). Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study. Arthritis Research & Therapy. 27(1). 91–91.
3.
Nakagawa, Kanako, et al.. (2023). The clock gene Bmal1 controls inflammatory mediators in rheumatoid arthritis fibroblast-like synoviocytes. Biochemical and Biophysical Research Communications. 691. 149315–149315. 3 indexed citations
4.
Yamamoto, Akiyuki, et al.. (2019). Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy. SHILAP Revista de lepidopterología. 5(4). 128–131. 2 indexed citations
5.
Terashima, Y., et al.. (2011). Short-term outcome of finger joint synovectomy in rheumatoid arthritis. Modern Rheumatology. 21(6). 598–601. 5 indexed citations
6.
Terashima, Y., et al.. (2011). Short-term outcome of finger joint synovectomy in rheumatoid arthritis. Modern Rheumatology. 21(6). 598–601. 5 indexed citations
7.
Hashiramoto, Akira, Kazuko Shiozawa, Yasushi Tanaka, et al.. (2009). Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose. Modern Rheumatology. 19(6). 637–642. 2 indexed citations
8.
Abe, Shuji, et al.. (2008). Total knee arthroplasty for rheumatoid knee with bilateral, severe flexion contracture: report of three cases. Modern Rheumatology. 18(5). 499–506. 4 indexed citations
9.
Kumagai, A, Yasuo Nagaoka, Y. Terashima, et al.. (2003). Tumor chemopreventive activity of 3- O -acylated (−)-epigallocatechins. Bioorganic & Medicinal Chemistry. 11(23). 5143–5148. 12 indexed citations
10.
Terashima, Y., Kunïkazu Kondo, & Yutaka Oiso. (1999). Administration of oxytocin affects vasopressin V2 receptor and aquaporin-2 gene expression in the rat. Life Sciences. 64(16). 1447–1453. 13 indexed citations
11.
Terashima, Y., Kunïkazu Kondo, Akemi Inagaki, et al.. (1998). Age-associated decrease in response of rat aquaporin-2 gene expression to dehydration. Life Sciences. 62(10). 873–882. 16 indexed citations
12.
Mizuno, Yumiko, Kunïkazu Kondo, Y. Terashima, et al.. (1998). Anorectic Effect of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) in Rats: Lack of Evidence for Involvement of Hypothalamic Neuropeptide Gene Expression. Journal of Neuroendocrinology. 10(8). 611–616. 54 indexed citations
13.
Terashima, Y., Kazumi Kondo, Yuji Mizuno, Yugo Iwasaki, & Yutaka Oiso. (1998). Influence of acute elevation of plasma AVP level on rat vasopressin V2 receptor and aquaporin-2 mRNA expression. Journal of Molecular Endocrinology. 20(2). 281–285. 13 indexed citations
14.
Sasaki, Hiroshi, Masakuni Furusato, Shin‐ichi Teshima, et al.. (1994). Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary. British Journal of Cancer. 69(3). 529–536. 12 indexed citations
15.
Sasaki, Hiroshi, H Nishii, Hirotaka Takahashi, et al.. (1993). Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.. PubMed. 53(8). 1906–10. 133 indexed citations
16.
Schoof, Deric D., et al.. (1992). Secondary cytokine production by lymphoid cells used in cellular immunotherapy. Surgical Oncology. 1(2). 163–172. 6 indexed citations
17.
18.
Ohkawa, Kiyoshi, Takashi Abe, Yutaka Tsukada, et al.. (1989). An Improved Sensitive Assay Method for the Heterogeneity of α-Foetoprotein: Possible Application for Early Differential Diagnosis. Clinical Chemistry and Laboratory Medicine (CCLM). 27(5). 337–41. 1 indexed citations
19.
Ohkawa, Kiyoshi, et al.. (1988). The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity. British Journal of Cancer. 58(1). 38–41. 43 indexed citations
20.
Nogami, Hiroshi, et al.. (1977). Congenital kyphoscoliosis and spinal cord lesion produced in the rat by β‐aminopropionitrile. Teratology. 16(3). 351–357. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026